Home > Cashflow Statement > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
Cashflow Statement

KILITCH DRUGS (INDIA) is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for KILITCH DRUGS (INDIA)
Please provide your vote to see the results

KILITCH DRUGS (INDIA) Last 5 Year Cashflow Statement History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Profit Before Tax₹39 Cr₹34 Cr₹19 Cr₹12 Cr₹9.61 Cr
Adjustment ₹7.95 Cr₹1.16 Cr₹10 Cr₹9.79 Cr₹3.89 Cr
Changes In working Capital ₹-12 Cr₹-9.63 Cr₹-24 Cr₹-15 Cr₹-5.19 Cr
Cash Flow after changes in Working Capital ₹34 Cr₹26 Cr₹5.50 Cr₹6.92 Cr₹8.32 Cr
Cash Flow from Operating Activities ₹24 Cr₹18 Cr₹-1.53 Cr₹2.59 Cr₹5.78 Cr
Cash Flow from Investing Activities ₹-100 Cr₹-40 Cr₹-8.16 Cr₹7.92 Cr₹-15 Cr
Cash Flow from Financing Activities ₹82 Cr₹13 Cr₹8.81 Cr₹-0.72 Cr₹7.03 Cr
Net Cash Inflow / Outflow ₹5.97 Cr₹-9.16 Cr₹-0.88 Cr₹9.78 Cr₹-2.44 Cr
Opening Cash & Cash Equivalents ₹9.80 Cr₹19 Cr₹20 Cr₹10 Cr₹13 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹16 Cr₹9.80 Cr₹19 Cr₹20 Cr₹10 Cr

Compare Cashflow Statement of peers of KILITCH DRUGS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA) ₹728.7 Cr 2.2% -4.2% 6.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,283.0 Cr 0.9% -5% 3.2% Stock Analytics
DIVIS LABORATORIES ₹251,611.0 Cr 3.6% -1.4% 37.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹175,182.0 Cr 1.7% -6.7% 28% Stock Analytics
CIPLA ₹109,063.0 Cr 2.8% -3.9% -17.5% Stock Analytics
DR REDDYS LABORATORIES ₹108,926.0 Cr 5.4% 8.7% 1.6% Stock Analytics


KILITCH DRUGS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA)

2.2%

-4.2%

6.8%

SENSEX

-0.3%

-1.6%

-12.3%


You may also like the below Video Courses